Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
1999 2
2002 2
2004 1
2009 1
2013 1
2016 1
2017 2
2018 3
2019 3
2020 1
2021 1
2022 1
2023 6
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.
De Laere B, Crippa A, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Bergström R, Chellappa V, Mayrhofer M, Banijamali M, Kotsalaynen A, Schelstraete C, Vanwelkenhuyzen JP, Hjälm-Eriksson M, Pettersson L, Ullén A, Lumen N, Enblad G, Thellenberg Karlsson C, Jänes E, Sandzén J, Schatteman P, Nyre Vigmostad M, Olsson M, Ghysel C, Sautois B, De Roock W, Van Bruwaene S, Anden M, Verbiene I, De Maeseneer D, Everaert E, Darras J, Aksnessether BY, Luyten D, Strijbos M, Mortezavi A, Oldenburg J, Ost P, Eklund M, Grönberg H, Lindberg J. De Laere B, et al. Among authors: everaert e. Nat Med. 2024 Nov;30(11):3291-3302. doi: 10.1038/s41591-024-03204-2. Epub 2024 Aug 20. Nat Med. 2024. PMID: 39164518 Free PMC article. Clinical Trial.
Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey.
Fontaine C, Libert I, Echterbille MA, Bonhomme V, Botterman J, Bourgonjon B, Brouillard V, Courtin Y, De Buck J, Debruyne PR, Delaat M, Delperdange JM, Duck L, Everaert E, Lamot C, Holbrechts S, Lossignol D, Krekelbergh F, Langenaeken C, Lapeire L, Naert E, Lauwers K, Matic M, Mebis J, Miedema G, Pieterbourg M, Plehiers B, Punie K, Roblain F, Schrijvers D, Serre CH, Vandenborre K, Broecke AV, Van den Bulk H, Vanopdenbosch L, Van Ryckeghem F, Verheezen J, Verschaeve V, Voordeckers M, Klastersky J. Fontaine C, et al. Among authors: everaert e. Support Care Cancer. 2024 Nov 20;32(12):811. doi: 10.1007/s00520-024-08984-4. Support Care Cancer. 2024. PMID: 39567437 Free article.
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial.
Crippa A, Laere B, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Hjälm-Eriksson M, Pettersson L, Enblad G, Ullén A, Lumen N, Karlsson CT, Sandzén J, Jänes E, Ghysel C, Olsson M, Sautois B, Schatteman P, Roock W, Bruwaene SV, Verbiene I, Darras J, Everaert E, Maeseneer D, Anden M, Strijbos M, Luyten D, Mortezavi A, Oldenburg J, Ost P, Lindberg J, Grönberg H, Eklund M; ProBio Investigators. Crippa A, et al. Among authors: everaert e. Eur Urol Oncol. 2025 Apr 21:S2588-9311(25)00037-9. doi: 10.1016/j.euo.2025.02.002. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40263079 Free article.
European value-based healthcare benchmarking: moving from theory to practice.
García-Lorenzo B, Gorostiza A, Alayo I, Castelo Zas S, Cobos Baena P, Gallego Camiña I, Izaguirre Narbaiza B, Mallabiabarrena G, Ustarroz-Aguirre I, Rigabert A, Balzi W, Maltoni R, Massa I, Álvarez López I, Arévalo Lobera S, Esteban M, Fernández Calleja M, Gómez Mediavilla J, Fernández M, Del Oro Hitar M, Ortega Torres MDC, Sanz Ferrandez MC, Manso Sánchez L, Serrano Balazote P, Varela Rodríguez C, Campone M, Le Lann S, Vercauter P, Tournoy K, Borges M, Oliveira AS, Soares M, Fullaondo A; VOICE Study Group. García-Lorenzo B, et al. Eur J Public Health. 2024 Feb 5;34(1):44-51. doi: 10.1093/eurpub/ckad181. Eur J Public Health. 2024. PMID: 37875008 Free PMC article.
35 results